NRTI induced mitochondrial toxicity as a mechanism for HAART related lipodystrophy: fact or fiction?
about
New and emerging agents in the management of lipodystrophy in HIV-infected patients.Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (HAART).HIV-associated lipodystrophy syndrome: A review of clinical aspects.Benefits of leptin therapy in HIV patients.Metabolic complications and treatment of perinatally HIV-infected children and adolescents.Treatment options for lipodystrophy in HIV-positive patients.HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options.Cytotoxicological analysis of a gp120 binding aptamer with cross-clade human immunodeficiency virus type 1 entry inhibition properties: comparison to conventional antiretroviralsPeripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in AccraMitochondrial DNA assessment in adipocytes and peripheral blood mononuclear cells of HIV-infected patients with lipodystrophy according to a validated case definition.Mean corpuscular volume (MCV) values reflect therapeutic effectiveness in zidovudine-receiving HIV patients.Study of oxidative, enzymatic mitochondrial respiratory chain function and apoptosis in perinatally HIV-infected pediatric patients.Quantitative analysis of human mitochondrial DNA using a real-time PCR assay.Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients.
P2860
Q35557229-B24CBC4B-940F-4E7F-A751-65C3BE3EDADCQ36068146-CA430E09-6FC7-44E7-977F-D192BB495532Q36171069-E82E44B9-4DE3-456F-A217-F6C840ED472AQ36700922-30FD6BD2-B32C-4A1B-8D6F-EF06EBF47DE6Q36952291-A6A7ED73-A256-4CD8-BA85-0BE32BB37485Q37030842-93684BA2-ABBF-49A1-8F7F-C5D838F5A797Q37195539-BFA44D9A-230E-4056-80BF-0FD9B5054F46Q37247615-EC0FF868-2075-4415-8186-9803AC486C80Q37291454-818D84E3-AC88-452F-A45E-75C2E126E615Q39244930-8A110CEA-3783-4B53-BC5E-F2DFD5A131FFQ40241691-5923BD79-8197-44A4-A813-92CCB3937BE2Q42269389-20A8FB9E-18BF-4BE3-B95E-A59AB9B5CA46Q43496856-982195A2-BA63-4DDC-BE7B-3EEB8ACD3682Q44511932-D17FC046-2D58-41B0-9A88-C5824B4FC475Q44738362-96CD7D67-E576-46D2-9CEF-9BBA7F15E24D
P2860
NRTI induced mitochondrial toxicity as a mechanism for HAART related lipodystrophy: fact or fiction?
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
NRTI induced mitochondrial tox ...... ipodystrophy: fact or fiction?
@ast
NRTI induced mitochondrial tox ...... ipodystrophy: fact or fiction?
@en
NRTI induced mitochondrial tox ...... ipodystrophy: fact or fiction?
@nl
type
label
NRTI induced mitochondrial tox ...... ipodystrophy: fact or fiction?
@ast
NRTI induced mitochondrial tox ...... ipodystrophy: fact or fiction?
@en
NRTI induced mitochondrial tox ...... ipodystrophy: fact or fiction?
@nl
prefLabel
NRTI induced mitochondrial tox ...... ipodystrophy: fact or fiction?
@ast
NRTI induced mitochondrial tox ...... ipodystrophy: fact or fiction?
@en
NRTI induced mitochondrial tox ...... ipodystrophy: fact or fiction?
@nl
P2860
P1433
P1476
NRTI induced mitochondrial tox ...... ipodystrophy: fact or fiction?
@en
P2093
P2860
P304
P356
10.1046/J.1464-2662.2001.00073.X
P577
2001-07-01T00:00:00Z